Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Subcommittee Postpones Pediatric Antidepressant Hearing

This article was originally published in The Pink Sheet Daily

Executive Summary

A conflict caused the Energy & Commerce/Oversight Subcommittee to postpone a July 20 hearing on clinical trial publication and disclosure issues. Results from a new study evaluating suicidal behavior in patients taking SSRIs versus tricyclic antidepressants could be a topic of discussion during the rescheduled hearing.
Advertisement

Related Content

Antidepressant Safety Concerns Not Impacting Forest's SSRI Sales
Antidepressant Safety Concerns Not Impacting Forest's SSRI Sales

Topics

Advertisement
UsernamePublicRestriction

Register

PS060029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel